Systolic Blood Pressure Intervention Trial (SPRINT)

Long Study Name: Systolic Blood Pressure Intervention Trial (SPRINT)

Study Type: cardiovascular

Study Purpose: This study will determine if reducing systolic blood pressure more than is currently recommended can reduce the risk of cardiovascular disease.

Study Design: This study will test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal than currently recommended will reduce cardiovascular disease (CVD) risk.

Study Qualifications

  • Age: 50 and older
  • Systolic blood pressure greater than 130
  • At least one other risk factor for cardiovascular disease

Study Duration

  • Up to 5 years

Study Benefits

  • Approved blood pressure medicine(s) provided at no cost to you
  • Health and medical screenings at no cost to you

Study Contact

If you are interested in the SPRINT study, call 336-713-8540 or email Lindsay Gordon at

Last Updated: 09-14-2015
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.